Last but not least, extra-mitochondria AML equipped cells could acquire additional anti-apoptotic proteins, also from the BCL-2 family, gaining a survival advantage and, possibly, resistance to standard therapy (160). Here, BCL2 is linked to acute myeloid leukemia.